Clinical trial
Tacrolimus Treatment of Patients With Idiopathic Focal Segmental…
NCT00302536 · Nanjing University School of Medicine, Other · Withdrawn
Key facts
| NCT number | NCT00302536 |
|---|---|
| Title | Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis |
| Official title | Tacrolimus Treatment of Patients With Idiopathic Focal Segmental |
| Lead sponsor | Nanjing University School of Medicine, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Focal Glomerulosclerosis |
| Intervention type | Drug |
| Interventions | Tacrolimus |
| Enrollment | 0 |
| Start date | Mar 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Mar 14, 2006 |
| Last update posted | Feb 9, 2012 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: